Agisilaos Zerdelis: My CRTH Journey From Trial Idea to Clinical Research
Agisilaos Zerdelis, Haematology Specialty Registrar at Cardiff and Vale University Health Board, shared a post on LinkedIn:
“That’s a wrap on CRTH.
These past months with the European Hematology Association (EHA) CRTH programme have taken a rough trial idea and turned it into something I’m genuinely proud of and taught me far more about clinical trial design than I expected along the way.
Mostly, though, it was the people.
Faculty who were generous with their time and expertise, and a cohort I’ve come to count as friends as much as colleagues.
Connections I’ll carry with me.
A particular thank you to Dr Mika Kontro for his mentorship and guidance throughout, it made a real difference.
An honour to have been part of it.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 16:48Abdul Rahman: Reticulocyte Count and Bone Marrow Activity
-
Oct 16, 2026, 16:44DOAC Adherence in Stroke Patients With Atrial Fibrillation – International Journal of Stroke
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs